Antithrombotic Agents for Secondary Prevention after Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

摘要

BackgroundNine oral antithrombotic medications currently available in the United States and Europe have been studied in clinical trials for secondary prevention of cardiac events following acute coronary syndrome (ACS). Few combinations of these medications have been directly compared, and studies have used multiple different comparator regimens.